6
Oct
2026

GALENICA S.A.

Exhibitor at CPHI Milan 2026 stand 5D129, Integrated Pharma
About Us

Founded in 1974, Galenica is a leading Greek pharmaceutical company dedicated to providing innovative therapeutic solutions across prescription and over-the-counter drugs, supplements, and medical devices. For over four decades, we have advanced human health through scientific innovation and a commitment to quality. Our production facilities in Chalkida and Kryoneri are EU GMP-certified and FDA-approved, producing various pharmaceutical forms including injectables, pills, and liquids. We adhere to strict safety, quality, and environmental standards, ensuring our products are trusted...

  • Country/Region:
    Greece
  • On CPHI since:
    2016
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
Distributor/Import Export
Licensee
Manufacturer/Innovator
Other
Pharmaceutical company
Primary activities
Contract Manufacturer
Out-licensing specialist
Pharmaceutical Company (innovator finished products)
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5D129, Integrated Pharma

Products Featured at CPHI Milan 2026

  • OXYMETAZOLINE THIXOTROPIC NASAL SPRAY

    Product OXYMETAZOLINE THIXOTROPIC NASAL SPRAY

    Active ingredient: Oxymetazoline Hcl
    0,5 mg/ml solution in 10 ml bottle 
    1 spray (100μl) contains 50 mcg Oxymetazoline Hcl
    Nasal metered dose spray



  • DIMENHYDRINATE SUBLINGUAL

    Product DIMENHYDRINATE SUBLINGUAL

    Active ingredient: Dimenhydrinate 50mg/tab
    Therapeutic target: Antinausea - motion sickness. 


    Contact us for more information.
  • DEXARIS

    Product DEXARIS

    Active ingredients:   Dexamethasone isonicotinate/ Oxymetazoline hydrochloride

    Therapeutic indications:
    Allergic rhinitis (hay fever, vasomotor rhinitis), acute rhinitis and rhinopharyngitis, sinusitis and nasal polyps.

  • DERMISET

    Product DERMISET

    Active ingredients: 
    Triamcinolone Acetonide+Salicylic Acid 

    Indications: 
    Eczema and corticosteroid-responsive skin diseases characterized by hyperkeratoses and/or squamous cell formation.
    Psoriasis, excluding large psoriasis plaques
    Lichenification of the skin.
    Neur...
  • CRETAN IAMA

    Product CRETAN IAMA

    Extracts from Corridothymus Capitatus, Salvia Fruticosa & Oreganum Dictamnus + Vit D3

    Maintenance of immune system
    Common cold and flu virus